João Goulão, MD

37
João Goulão, MD Portuguese National Coordinator for Drug Problems, Drug Addictions and the Harmful Use of Alcohol General-Director of the Intervention on Addictive Behaviours and Dependencies DG Chairman, European Monitoring Center on Drugs and Drug Addiction (EMCDDA) Decriminalisation: Definitions and models of delivery 14th March 2013 International Drug Policy Consortium 1

description

Decriminalisation : Definitions and models of delivery 14th March 2013 International Drug Policy Consortium. João Goulão, MD Portuguese National Coordinator for Drug Problems, Drug Addictions and the Harmful Use of Alcohol - PowerPoint PPT Presentation

Transcript of João Goulão, MD

Page 1: João Goulão, MD

1

João Goulão, MD

Portuguese National Coordinator for Drug Problems, Drug Addictions and the Harmful Use of Alcohol

General-Director of the Intervention on Addictive Behaviours and Dependencies DG

Chairman, European Monitoring Center on Drugs and Drug Addiction (EMCDDA)

Decriminalisation: Definitions and models of delivery

14th March 2013

International Drug Policy Consortium

Page 2: João Goulão, MD

2

Page 3: João Goulão, MD

3

Resident population 10 627 250

North/South territorial units maximum length 652 km

East/West territorial units maximum length

218 km

Surface 92 090 Km2

Page 4: João Goulão, MD

4

Page 5: João Goulão, MD

5

It began much latter than in the other Western European Countries;

It happened with relevance only after the Portuguese Democratic Revolution (1974), when society was facing lots of deep and accelerated changes;

society unprepared to new phenomenon; closed and isolated country;return of soldiers and colons from ancient colonies It developed very fast; society was not able to

answer in the right time and to face the “new needs” created by drug use; as a consequence, there was a gap between the appearance of the “needs” and the “answers”

The history of Drug Use in Portugal

Page 6: João Goulão, MD

6

Page 7: João Goulão, MD

7

Drug use spread under European average level;But a considerable number of “problematic drug

users” appeared and, during a long period of time, had no access to treatment (small gap between “total” and “problematic” drug users);

By the end of the 20th Century, Portugal had one of the highest prevalence of Problematic Drug Use, at European Level

(1% -100 000 problematic drug users);At the same time, the social burden, associated to

drug use, was very relevant – top political concern

As a consequence:

Page 8: João Goulão, MD

8

The complexity of the situation called for some measures expected to reverse that cycle

A new National Strategy was built, recommended by an expert group (1999)

A new Legal Framework was approved by the Parliament (Law 30/2000); good social acceptance; huge political debate

A new institutional structure was created to implement and coordinate an Integrated Approach to all the areas related to Drugs and Drug Use – IDT (Institute on Drugs and Drug Addiction)

Page 9: João Goulão, MD

9

Page 10: João Goulão, MD

10

The Portuguese Drugs Strategy elaborated on the past policy consumption’s criminalization and on the need to liberate resources for the fight against drug trafficking:

Imprisonment or fee (the most common sentence imposed on 1st time offenders) didn’t solve drug abuse;

In the case of 1st time offenders or occasional users, imprisonment is likely to produce counterproductive effects;

A New Paradigm

Page 11: João Goulão, MD

11

• Established 8 Principles, among which the Humanistic Principle:– Recognition of the human person’s full dignity;– Understanding the human person’s life, clinical

record and social environment;– Assumption that the drug user is a diseased

person endowed with the constitutional right to health;

– Offender’s full responsibility.

1999 National Drugs Strategy

Page 12: João Goulão, MD

12

A new destination for drug tourism?Compliance with the UN Conventions?Increase of drug use in younger groups?

Administrative sanctions in line with UN Conventions

Positive references in: April 2004 International Narcotics Control Board

Mission to Portugal; World Drug Report 2009; The Cato Institute Greenwald Report – April 2009; The 2009 EMCDDA Annual Report; The British Journal of Criminology, Caitlin Hughes

and Alex Stevens – November 2010; Drug Policy in Portugal, The Benefits of

Decriminalizing Drug Use – Open Society Institute, June 2011.

Challenges

Page 13: João Goulão, MD

13

Law No. 30/2000: the consumption, acquisition and possession for own consumption of plants, substances or preparations constitute an administrative offence and can not exceed the quantity previewed for individual use for a 10 days period. Exceeding this quantity, criminal procedures take place.

• The drug addict is viewed as a sick person in need of health care;

• The dissuasion intervention provides an opportunity for an early, specific and integrated interface with drug users;

• The dissuasion intervention is aimed and targeted to the drug users’ characteristics and individual needs.

The Dissuasion Model

Page 14: João Goulão, MD

14

Ten Days Maximum Amount Allowed Illicit Substance Chart

Illicit Substance Grams

Heroin 1Methadone 1Morphine 2Opium 10Cocaine (hydrochloride) 2Cocaine (methyl ester benzoilegonine) 0.3

Cannabis (leaves and flowers or fruited dons) 25

Cannabis (resin) 5Cannabis (oil) 2.5LSD 0.1MDMA 1Amphetamine 1

Page 15: João Goulão, MD

15

• To dissuade consumption – a “second line” of preventive intervention – the “yellow card”;

• To prevent and reduce drug use and abuse;• To ensure the sanitary protection of users and the

community;• To liberate resources for the fight against drugs

trafficking and crime related, such as the small crime to acquire drugs for one’s own consumption.

Dissuasion Objectives

Page 16: João Goulão, MD

16

• Users’ information and awareness to drug consumption risks;

• Promotion of health in global terms;• Promotion of users’ social reintegration;• Drug addicts motivation and referral to treatment;• Signalization of situations that, thought not

characterized as drug addiction, need to be specifically addressed.

Dissuasion Tools

Page 17: João Goulão, MD

Composition of the Commissions

President and two other members

Appointed by the Minister of Justice and by the Minister of

Health

Multidisciplinary technical unit support – Psychologists, social service workers, lawyers

and administrative workers

Prepare all facts and make previous evaluation that supports the decision

Motivation of the user to undergo for treatmentGuarantee the function of network

17

Page 18: João Goulão, MD

18

ProcedurePolice

Authority

Commission•Psychological and social evaluation

• Hearing the user• Decision

•A person is found at a public place in possession or using drugs•Occurrence police report •The user is brought to the commission in a maximum delay of 72h

Motivation work

Situation regarding drug usePsychosocial situationPrevious register

Execution of penalties

File ProceedingsWhen the suspension period expires and the user stopped to use drugs without record of relapse, or if penalties were carried out

Page 19: João Goulão, MD

19

Network

Coordination between services with responsibilities in this area

Treatment Addicts Centre

Health Centre

Police Authorities

Employment and Training Services

Welfare Services

Schools

Primary Prevention Activities Prisons

Page 20: João Goulão, MD

20

• Provisional Process Suspension;• Periodic Presentation to the Drug Addiction

Dissuasion Commissions;• Admonition, Warning;• Community Service;• Forbiddance of attending certain places;• Periodic presentation to Drug Addiction Dissuasion

Commissions;• Apprehension of objects;• Interdiction to travel;• Interdiction of receiving subsidies or other monetary

social grants;• Monetary fee.

Decisions and Sanctions

Page 21: João Goulão, MD

21

•Some Results

Page 22: João Goulão, MD

22

Annual Distribution of processes CDT 2001-2011

Source: IDT, I.P.

2001* 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 1,000

2,000

3,000

4,000

5,000

6,000

7,000

8,000

9,000

2.246

6.025

6.785

5.900

7.365

6.972

7.432 7.342

8.441

7.870

7,388

Page 23: João Goulão, MD

23

Type of administrative sanctions by year

Source: IDT, I.P./ DMFRI – NE

2005 2006 2007 2008 2009 2010 2011

1000

2000

3000

4000

1892

17782010

2880

3719

2765

3259

683 597 623

829 825 875745

69 6888 102

70 62 72

476 516 571 670 768

634 740

72 61 46 121

78 99 217

Prov. Susp. Non Addict Prov. Susp. With Treatment Susp. Of the rulling/execution Punitive

Aquittal

Pro

cess

es

Page 24: João Goulão, MD

24Source: IDT, I.P./ DMFRI – NE

Type of drug involved in administrative sanctions by year

2005 2006 2007 2008 2009 2010 2011

1000

2000

3000

4000

5000

6000

864789

1089841 803 959

610

362 395 484 460

438

468

461

4015 4043 4104 4163

5429

4920 4934

628 526625

580

424

506

429

Heroin Cocaine Cannabis Polydrugs

Pro

cess

es

Page 25: João Goulão, MD

31

Treatment Public Network

22 CRI– Integrated Units (Treatment, Harm Reduction, Prevention and Reintegration)

45 Drug Treatment Teams(and more 32 outpatient units)

3 Therapeutic Communities4 Detoxification Units

2 Day CentresSource: IDT, I.P./ DMFRI – NE

Page 26: João Goulão, MD

32

Outpatients Clients in the Public Network

Source: IDT, I.P./ DMFRI – NE

2005 2006 2007 2008 2009 2010 2011

5 000

10 000

15 000

20 000

25 000

30 000

35 000

40 000

100 000

200 000

300 000

400 000

500 000

600 000

700 000

31 822 32 460 34 266

38 532 38 875 37 983 38 292

4844 4745 51247019 7643 8444 8492

406 410 428 855

467 789

616 658

614 213

458 987 469 678

Clients Total Clients First Treatment Demands Follow-up treatment episodes

Clie

nts

Trea

tmen

t Epi

sode

s

Page 27: João Goulão, MD

33

-14 15 - 19 20 - 24 25 - 29 30 - 34 35 - 39 40 - 44 45 - 49 50 - 54 55 - 59 60 - 64 65 - 690%

5%

10%

15%

20%

25%

30%

35%

Average age evolution of the IDT first clients, users of other psychoactive substances

199519982001200420072010

Source: IDT, I.P.

Page 28: João Goulão, MD

34

1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 20110%

20%

40%

60%

80%

100%

120%

Clients distribution by Year and Main Drug

CannabisCocaínaHeroína

Source: IDT, I.P.

Page 29: João Goulão, MD

35

Drug Injecting on the Previous 30 days before New Patients 1st Consultation - Public Treatment Network

2000 - 2010

Source: IDT, I.P./ DMFRI – NE

2003 2004 2005 2006 2007 2008 2009 2010* 2011*0

5

10

15

20

25

30 28

25

21 20

17

14

1011 11.2180239380427

%

Page 30: João Goulão, MD

36

Diagnosis of HIV infection by characteristics of sampled population

Portugal 1983-2009N

umbe

r of

dia

gnos

is

Source: National Coordination for HIV/AIDS Infection

Year of diagnosis

2005 2006 2007 2008 2009 2010 2011

10,000

20,000

30,000

21,054

22,92224,312

25,808 27,03127,392

26,351

Users in Therapeutic Programs with Opiate Agonists 2005-2011

Uten

tes

Page 31: João Goulão, MD

37

Small increases in reported illicit drug use amongst adults

Reduced illicit drug use among adolescents, at least since 2003

Reduced burden of drug offenders on the criminal justice system

Reduction in the prevalence of injecting drug use Reduction in opiate-related deaths and infectious

diseases Reduced stigmatization of drug users Increases in the amounts of drugs seized by the

authorities Reductions in the retail prices of drugs Increased efficiency of Police and Customs forces.

Trends since 2001

Page 32: João Goulão, MD

38

We do not establish a causal effect of decriminalisation to the results

Comprehensive responses as a whole

But, for sure,

Decriminalisation did not affect negatively the evolution of the phenomenon

Final Remarks

Page 33: João Goulão, MD

CONCLUSIONS:

There is a coherent articulation among ALL THE PORTUGUESE POLICY AND ACTIONS

based on the idea that DRUG ADDICT is a SICK PERSON with treatment needs

instead of being addressed as a “CRIMINAL or a DELIQUENT”.

Until now, the global drug situation in Portugal seems to have a positive evolution in all the

available indicators.

39

Page 35: João Goulão, MD

41

Page 36: João Goulão, MD

42

Reinsertion

DissuasionTreatment

Prevention

Harm Reduction

Page 37: João Goulão, MD

43

General-Directorate for Intervention on Addictive Behaviours and

Dependencies

[email protected]

Thank you for your attention